Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome.
Chronic prostatitis/chronic pelvic pain syndrome continues to pose a treatment challenge for urologists. Most commonly prescribed medications, such as antibiotics, a-blockers, androgen inhibitors, and anti-inflammatory agents, have been shown to help some patients. However, the efficacy and durability of such treatments lack consistency among men suffering from this disorder. The rationale for such treatments is described in this article, along with possible explanations for the apparent shortcomings. Also included is a brief summary of alternative therapies, which are growing in popularity among patients and gaining acceptance in our medical communities.
Potts
Jeannette M
JM
Glickman Urological Institute, 9500 Euclid Avenue, A/100, Cleveland, OH 44195, USA. pottsj@ccf.org
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017699:Pelvic Pain / Q000188:drug therapy*; D008517:Phytotherapy; D010936:Plant Extracts / Q000627:therapeutic use; D011472:Prostatitis / Q000188:drug therapy*; D012434:Secale; D013577:Syndrome
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D000893:Anti-Inflammatory Agents; D004791:Enzyme Inhibitors; D010936:Plant Extracts; D018120:Finasteride; C010070:cernilton